Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel [etanercept] in Psoriasis

Trial Profile

Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel [etanercept] in Psoriasis

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Etanercept (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Mar 2010 Actual end date (1 Feb 2010) added as reported by ClinicalTrials.gov.
    • 09 Mar 2010 Actual patient number (231) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top